News

Chemist’s Innovation Spurs Drugs that Hang on Through Thick and Thin

October 27, 2023 • by Emily Engelbart

The newly launched Hyku Biosciences provides a platform for covalent drug development which may be a better approach for treating diseases like cancer.

Using SuTex, short for sulfur-triazole exchange chemistry, Ken Hsu has created an approach to target sites on proteins that have extra electrons to share. This covalent bond is very stable compared with bonds formed by traditional drugs. Credit: Zhihong Li

Accolades

Emmie Stumbo Receives Safety Fellowship

October 20, 2023 • by Staff Writer

Accolades

Chemistry Graduate Student Awards Showcase 2023

October 16, 2023 • by Staff Writer

Accolades

Diana Zamora-Olivares Receives Stanley J. Roux, Jr. Excellence in Experiential Teaching Award

October 3, 2023 • by Staff Writer

Accolades

Lynn Stevens Receives POLY Graduate Student Travel Award

October 3, 2023 • by Staff Writer

Accolades

Devleena Samanta and Pedro Metola Receive Teaching Excellence Award

September 28, 2023 • by Staff Writer

Announcements

Ken Hsu Founder of New Biotech Company

September 25, 2023 • by Staff Writer

Accolades

Yi-Chih Lin Receives NIH Maximizing Investigators' Research Award

September 20, 2023 • by Staff Writer

Research

Five Lessons from UT Austin Science about Planning for Living with Heat

August 23, 2023 • by Emily Engelbart

In our endless summer, research on heat impacts offers insights on how best to adapt.

CNS Scientists have been applying their research in ways that will help communities respond to heat.

Accolades

Muhammad Waqas Ishaq Named Provost’s Early Career Fellow

August 14, 2023 • by Staff Writer